Cachexia and Sarcopenia in Oligometastatic Non-Small Cell Lung Cancer: Making a Potential Curable Disease Incurable?

Cancers (Basel) · 2024 · PMC10777972 · PMID 38201657

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Compared with the 64.7% of patients proceeding to LRT in group A (no cachexia and no sarcopenia), a smaller percentage of patients with cachexia only (56.5%), sarcopenia only (55.9%), and both cachexia and sarcopenia (52.4%) proceeded to LRT, although this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.